Intelligence > NAI Interview

NAI Interview

A Canadian Hemp Company Steps into Asia Market

04/10/2017 2 p.m.

A Leading Provider of High Quality Plant-Based Functional Foods and Ingredients – Interview with Naturally Splendid Enterprises Ltd. ... Full Story

Interview with Douglas MacQuarrie, President & CEO of Asante Gold Corporation - A Gold Driven, Ghana Focused Exploration Company

02/10/2017 2:41 p.m.

Asante Gold Corporation (CSE:ASE) is a Vancouver, Canada based gold exploration company with its operations based in the African nation of Ghana, the world’s ninth largest gold producer. The Company... Full Story

A Canadian IT Portfolio Management Company Steps into the China Market - Interview with Johnson Joseph, CEO of Peak Positioning Technologies Inc.

02/08/2017 10:36 a.m.

Peak Positioning Technologies Inc. (CSE: PKK), a Canadian IT portfolio management company recently had its China-based subsidiary, Asia Synergy Technologies, reach C$50M revenue milestone after less than fou... Full Story

A Rapidly Emerging Rare Earth Project in Labrador, Canada – Interview with Greg Andrews, President and CEO of Search Minerals Inc.

01/06/2017 4:02 a.m.

What is Search Minerals currently focused on and what are the opportunities? Search Minerals Inc. Search is focusing on 5 of these critical rare earth elements which have constricted supply an... Full Story

Striving Forward Despite Diminishing Steel Production in China

11/17/2016 5:01 p.m.

China’s economy is currently growing at its lowest rate in the past 25 years. The Chinese central government has emphasized, in many occasions, structural economic adjustments including “cutting ... Full Story

Interviews with Jon Stern, CEO of Cohbar Inc.

12/15/2015 9:26 p.m.

NAI500 is delighted to spend some time with the CEO of Cohbar Inc. (TSXV:COB.U), one of the emerging life science companies in the pre-clinical stage that tackles aging related diseases.    ... Full Story

Disrupting Treatment of Cardiovascular Disease with Epigenetics: Resverlogix CEO Donald McCaffrey

10/19/2015 11:45 p.m.

The evidence is mounting: Resverlogix Corp.'s first-in-class, epigenetics-based drug candidate has demonstrated its ability to significantly reduce major adverse cardiac events (MACE)—death, he... Full Story

Harness Biotech Volatility with an Options Strategy: Theta Strategy Capital's Eden Rahim

08/17/2015 5:10 p.m.

Volatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That's the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies Capital. Can... Full Story

Search Articles

Company Search

Upcoming Events More